PASADENA, Calif., Jan. 30, 2012 /PRNewswire/ -- Alexandria Real Estate Equities, Inc. (NYSE: ARE) announced today the tax treatment of its Year 2011 distributions as described in the chart below. Shareholders are encouraged to consult with their own tax advisors as to their specific tax treatment of Alexandria Real Estate Equities, Inc. distributions.


                                                                                                Dividends              Capital Gains
                                                                                                ---------              -------------
               Record Date                  Payment Date      Distribution Per Share         Taxable Ordinary          Qualified (1)           Total Capital Gain          Unrecaptured Section 1250 (2)   Return of Capital (3)
               -----------                  ------------      ----------------------        ----------------           ------------            ------------------          ----------------------------    --------------------


    Common Stock (Cusip # 015271109)
    -------------------------------
                 12/30/10                             1/17/11                    $0.450000                  $0.430650      $                -                   $0.005850              $                -                    $0.013500
                 3/31/11                              4/15/11                    $0.450000                  $0.430650      $                -                   $0.005850              $                -                    $0.013500
                 6/30/11                              7/15/11                    $0.450000                  $0.430650      $                -                   $0.005850              $                -                    $0.013500
                 9/30/11                             10/17/11                    $0.470000                  $0.449790      $                -                   $0.006110              $                -                    $0.014100

    Total                                                                        $1.820000                  $1.741740      $                -                   $0.023660              $                -                    $0.054600
                                                                                 =========                  =========      ==================                   =========              ==================                    =========
    Percentage                                                                       100.0%                      95.7%                    0.0%                        1.3%                            0.0%                         3.0%

    Series C Preferred Stock (Cusip # 015271406)
    -------------------------------------------
                 12/30/10                             1/17/11                    $0.523438                  $0.516109      $                -                   $0.007328              $                -           $                -
                 3/31/11                              4/15/11                    $0.523438                  $0.516109      $                -                   $0.007328              $                -           $                -
                 6/30/11                              7/15/11                    $0.523438                  $0.516109      $                -                   $0.007328              $                -           $                -
                 9/30/11                             10/17/11                    $0.523438                  $0.516109      $                -                   $0.007328              $                -           $                -

    Total                                                                        $2.093750                  $2.064438      $                -                   $0.029313              $                -           $                -
                                                                                 =========                  =========      ==================                   =========              ==================           ==================
    Percentage                                                                       100.0%                      98.6%                    0.0%                        1.4%                            0.0%                         0.0%

    Series D Preferred Stock (Cusip # 015271505)
    -------------------------------------------
                 12/30/10                             1/17/11                    $0.437500                  $0.431375      $                -                   $0.006125              $                -           $                -
                 3/31/11                              4/15/11                    $0.437500                  $0.431375      $                -                   $0.006125              $                -           $                -
                 6/30/11                              7/15/11                    $0.437500                  $0.431375      $                -                   $0.006125              $                -           $                -
                 9/30/11                             10/17/11                    $0.437500                  $0.431375      $                -                   $0.006125              $                -           $                -

    Total                                                                        $1.750000                  $1.725500      $                -                   $0.024500              $                -           $                -
                                                                                 =========                  =========      ==================                   =========              ==================           ==================
    Percentage                                                                       100.0%                      98.6%                    0.0%                        1.4%                            0.0%                         0.0%


    (1) Qualified dividends is a subset of, and included in, the taxable ordinary dividend amount.
    (2) Unrecaptured section 1250 gain is a subset of, and included in, the total capital gain amount.
    (3) Represents a return of shareholder investment.

Alexandria Real Estate Equities, Inc., a self-administered and self-managed real estate investment trust, is the largest owner and preeminent REIT focused principally on science-driven cluster formation. Our operating platform is based on the principle of "clustering" with high-quality assets and operations located adjacent to life science research and innovation entities driving growth and technological advances. Alexandria has significant real estate assets adjacent to these key life science entities which we believe results in higher occupancy levels, longer lease terms, higher rental income, and higher returns. Our targeted locations are in the best submarkets within each of the top life science cluster destinations, including San Francisco and San Diego, California; Greater Boston; New York City, New Jersey, and Suburban Philadelphia; Research Triangle Park, North Carolina; Suburban Washington, D.C.; Seattle, Washington; and international locations. Client tenants include institutional (universities and independent non-profit institutions), pharmaceutical, biotechnology, medical device, product, and service entities, and government agencies. Alexandria's primary business objective is to maximize stockholder value by providing its stockholders with the greatest possible total return based on a multifaceted platform of internal and external growth. The key elements to our strategy include our consistent focus on high-quality assets and operations in the top life science cluster destinations with our properties located adjacent to life science entities driving growth and technological advances within each cluster. These adjacency locations are characterized by high barriers to entry and exit, limited supply of available space, and represent highly desirable locations for tenancy by life science entities. Alexandria's strategy also includes leveraging on its deep and broad life science and real estate relationships in order to attract new and leading life science client tenants and value-added real estate opportunities through acquisitions, redevelopment, and development.

SOURCE Alexandria Real Estate Equities, Inc.